ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Evaluation of two inactivated vaccines against Campylobacter fetus in an experimental bovine model: immunological survey and genital clearance in heifers.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine Genital Campylobacteriosis is a venereal disease caused by Campylobacter fetus subsp. venerealis (Cfv), responsible for reproductive losses in breeding systems that rely on natural service. Here, we evaluated 2 vaccines against Cfv infection in heifers experimentally challenged by intravaginal route, assessing bacterial persistence and immunological systemic and local response. Forty-four heifers were assigned to 4 groups: G1 (vaccine A), G2 (vaccine B), G3 (infected group with placebo) and G4 (negative control). Experimental intravaginal challenge with Cfv was carried out in G1, G2 and G3, and followed up for 105 days after. A significant difference in positivity through bacteriological culture in vaginal cervical mucus was observed between the vaccinated groups (61,81% in G1 and 45,45% in G2) and the infected group (87,27% in G3) (p < 0.05). Local specific antibodies (IgA) and systemic (IgG) were detected by ELISA in all groups experimentally challenged, though, the vaccinated groups (G1 and G2) showed an earlier increase. Additionally, agglutinating antibodies were observed after vaccination, mainly for group G2 (p = 0.0316). Through qPCR a lower load of bacteria resulted in vaccinated cattle during the sampling period. We conclude that vaccinated heifers showed a significantly earlier clearance of Cfv from the reproductive tract compared to unvaccinated heifers, associated to high-early levels of systemic and local Ig. These vaccines are a potential preventive measure that requires natural field cases to evaluate reproductive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.